Rovi Prioritizes Risperidone Filing In Europe Over US

 
• By Aidan Fry
  
Flags
Rovi plans to file for its long-acting injectable formulation of risperidone in Europe before submitting its dossier in the US • Source: Shutterstock

More from Value Added Medicines

More from Products